• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国心力衰竭患者因医疗费用导致的主观经济困难:2014-2018 年医疗支出面板调查。

Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014-2018 Medical Expenditure Panel Survey.

机构信息

Department of Cardiology, Houston Methodist Hospital, Houston, Texas, USA.

Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA; Center for Outcomes Research, Houston Methodist, Houston, Texas, USA.

出版信息

J Card Fail. 2022 Sep;28(9):1424-1433. doi: 10.1016/j.cardfail.2022.06.009. Epub 2022 Jul 15.

DOI:10.1016/j.cardfail.2022.06.009
PMID:35839928
Abstract

BACKGROUND

Heart failure (HF) poses a substantial economic burden on the United States (US) health care system. In contrast, little is known about the financial challenges faced by patients with HF. In this study, we examined the scope and sociodemographic predictors of subjective financial hardship due to medical bills incurred by patients with HF.

METHODS

In the Medical Expenditure Panel Survey (MEPS; years 2014--2018), a US nationally representative database, we identified all patients who reported having HF. Any subjective financial hardship due to medical bills was assessed based on patients' reporting either themselves or their families (1) having difficulties paying medical bills in the past 12 months, (2) paying bills late or (3) being unable to pay bills at all. Logistic regression was used to evaluate independent predictors of financial hardship among patients with HF. All analyses took into consideration the survey's complex design.

RESULTS

A total of 116,563 MEPS participants were included in the analysis, of whom 858 (0.7%) had diagnoses of HF, representing 1.8 million (95% CI 1.6-2.0) patients annually. Overall, 33% (95% CI 29%-38%) reported any financial hardship due to medical bills, and 13.2% were not able to pay bills at all. Age ≤ 65 years and lower educational attainment were independently associated with higher odds of subjective financial hardship due to medical bills.

CONCLUSION

Subjective financial hardship is a prevalent issue for patients with HF in the US, particularly those who are younger and have lower educational attainment. There is a need for policies that reduce out-of-pocket costs for the care of HF, an enhanced identification of this phenomenon in the clinical setting, and approaches to help minimize financial toxicity in patients with HF while ensuring optimal quality of care.

摘要

背景

心力衰竭(HF)给美国(US)医疗保健系统带来了巨大的经济负担。相比之下,人们对 HF 患者所面临的财务挑战知之甚少。在这项研究中,我们研究了 HF 患者因医疗费用而导致主观经济困难的范围和社会人口统计学预测因素。

方法

在医疗支出面板调查(MEPS;2014-2018 年)中,我们确定了所有报告患有 HF 的患者。根据患者或其家属报告的以下任何一种情况,评估因医疗费用而导致的主观经济困难:(1)在过去 12 个月内有支付医疗费用的困难,(2)延迟支付账单或(3)根本无法支付账单。使用逻辑回归评估 HF 患者经济困难的独立预测因素。所有分析均考虑了调查的复杂设计。

结果

共纳入 116563 名 MEPS 参与者进行分析,其中 858 名(0.7%)患有 HF 诊断,代表每年 180 万(95%CI 1.6-2.0)名患者。总体而言,33%(95%CI 29%-38%)报告因医疗费用而有任何经济困难,13.2%的人根本无法支付账单。年龄≤65 岁和较低的教育程度与因医疗费用而导致主观经济困难的几率较高独立相关。

结论

主观经济困难是美国 HF 患者普遍存在的问题,尤其是年龄较小和教育程度较低的患者。需要制定政策来降低 HF 护理的自付费用,在临床环境中更准确地识别这种现象,并采取措施帮助 HF 患者减轻财务毒性,同时确保提供最佳的护理质量。

相似文献

1
Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014-2018 Medical Expenditure Panel Survey.美国心力衰竭患者因医疗费用导致的主观经济困难:2014-2018 年医疗支出面板调查。
J Card Fail. 2022 Sep;28(9):1424-1433. doi: 10.1016/j.cardfail.2022.06.009. Epub 2022 Jul 15.
2
Financial Hardship Among Nonelderly Adults With CKD in the United States.美国非老年慢性肾脏病患者的经济困难。
Am J Kidney Dis. 2021 Nov;78(5):658-668. doi: 10.1053/j.ajkd.2021.04.011. Epub 2021 Jun 16.
3
Measures of Financial Hardship From Health Care Expenses Among Families With a Member With Atherosclerotic Cardiovascular Disease in the US.美国动脉粥样硬化性心血管疾病患者家庭的医疗支出导致经济困难的衡量标准。
JAMA Health Forum. 2022 Jul 22;3(7):e221962. doi: 10.1001/jamahealthforum.2022.1962. eCollection 2022 Jul.
4
Association of Financial Hardship Because of Medical Bills With Adverse Outcomes Among Families of Children With Congenital Heart Disease.因医疗账单导致经济困难与先天性心脏病患儿家庭不良结局的相关性研究。
JAMA Cardiol. 2021 Jun 1;6(6):713-717. doi: 10.1001/jamacardio.2020.6449.
5
Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States.美国非老年糖尿病成年人医疗费用导致的经济困难负担及后果
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006139. doi: 10.1161/CIRCOUTCOMES.119.006139. Epub 2020 Feb 6.
6
Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States.慢性肝病患者医疗费用导致的经济困难:来自美国的全国估计数据。
Hepatology. 2021 Sep;74(3):1509-1522. doi: 10.1002/hep.31835. Epub 2021 Jun 2.
7
Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States.美国非老年成年人在糖尿病和动脉粥样硬化性心血管疾病谱系中因医疗费用导致的经济负担累积情况。
J Am Heart Assoc. 2020 May 18;9(10):e015523. doi: 10.1161/JAHA.119.015523. Epub 2020 May 12.
8
Health Care Expenses and Financial Hardship Among Medicare Beneficiaries With Functional Disability.有功能障碍的 Medicare 受益人的医疗保健费用和经济困难。
JAMA Netw Open. 2024 Jun 3;7(6):e2417300. doi: 10.1001/jamanetworkopen.2024.17300.
9
Out-of-Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States.美国心力衰竭患者的自付年度医疗支出和医疗成本所致经济毒性。
J Am Heart Assoc. 2021 Jul 20;10(14):e022164. doi: 10.1161/JAHA.121.022164. Epub 2021 May 16.
10
Association of Medicare Advantage Enrollment With Financial Burden of Care : A Retrospective Cohort Study.医疗保险优势计划参保与医疗负担的关联:一项回顾性队列研究。
Ann Intern Med. 2024 Jul;177(7):882-891. doi: 10.7326/M23-2480. Epub 2024 Jun 25.

引用本文的文献

1
Heart Failure Beyond the Diagnosis: A Narrative Review of Patients' Perspectives on Daily Life and Challenges.心力衰竭诊断之外:关于患者对日常生活及挑战看法的叙述性综述
J Clin Med. 2024 Nov 29;13(23):7278. doi: 10.3390/jcm13237278.
2
Integrating Out-of-Pocket Costs Into Shared Decision-Making for Heart Failure With Reduced Ejection Fraction: A Stepped-Wedge Trial (POCKET-COST-HF).将自付费用纳入射血分数降低的心力衰竭共同决策:一项阶梯楔形试验(POCKET-COST-HF)
Circ Cardiovasc Qual Outcomes. 2025 Jan;18(1):e011273. doi: 10.1161/CIRCOUTCOMES.124.011273. Epub 2024 Dec 3.
3
A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health.
代价高昂的治疗:在健康的社会决定因素领域中理解和应对心血管疾病医疗保健中的经济毒性。
Methodist Debakey Cardiovasc J. 2024 Nov 5;20(5):15-26. doi: 10.14797/mdcvj.1466. eCollection 2024.
4
Social Risks and Health Care Use in Medically Complex Patients.医疗复杂患者的社会风险与医疗保健使用
JAMA Netw Open. 2024 Sep 3;7(9):e2435199. doi: 10.1001/jamanetworkopen.2024.35199.
5
Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits.推进心力衰竭的指南导向医学治疗:克服挑战并最大化获益。
Am J Cardiovasc Drugs. 2024 May;24(3):329-342. doi: 10.1007/s40256-024-00646-4. Epub 2024 Apr 3.
6
Perceived Economic Burden, Mortality, and Health Status in Patients With Heart Failure.心力衰竭患者的经济负担感知、死亡率和健康状况。
JAMA Netw Open. 2024 Mar 4;7(3):e241420. doi: 10.1001/jamanetworkopen.2024.1420.
7
Novel cardiovascular therapeutics and the risk of financial toxicity.新型心血管治疗方法与经济毒性风险。
Nat Rev Cardiol. 2024 Jun;21(6):349-350. doi: 10.1038/s41569-024-01010-4.
8
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.消除心房颤动、心力衰竭和血脂异常中的健康差异:实现药物平等的途径。
Curr Atheroscler Rep. 2023 Dec;25(12):1113-1127. doi: 10.1007/s11883-023-01180-5. Epub 2023 Dec 18.
9
Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.通用心脏病药物价格:马克·库班成本加成制药公司模式的潜在益处
Front Pharmacol. 2023 Aug 22;14:1179253. doi: 10.3389/fphar.2023.1179253. eCollection 2023.
10
Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.心力衰竭医学管理的经济毒性:JACC 本周综述主题。
J Am Coll Cardiol. 2023 May 23;81(20):2043-2055. doi: 10.1016/j.jacc.2023.03.402.